Patent US5308320A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4803075A Expired / Lapsed US ⏱️ 0.0 years remaining

Injectable implant composition having improved intrudability

Assignee: Allergan Inc
•
Filing: 1986-06-25
•
Granted: 1989-02-07
•
Expires: 2006-06-25
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Injectable aqueous suspensions of biomaterials, such as cross-linked collagen, that contain a biocompatible fluid lubricant, such as glycogen or maltose, are disclosed. The inclusion of the lubricant significantly improves the intrusion of the suspension into soft tissue.

Inventors

  • 👤 Donald G. Wallace
  • 👤 Hertsel Reihanian
  • 👤 Bruce B. Pharriss
  • 👤 William G. Braun

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 12:48
CPC Classifications
A; A61; A61K; A61K38/00; A61K38/16; A61K38/17; A61K38/39; A61L; A61L27/00; A61L27/14; A61L27/22; A61L27/24; A61L27/26; A61L27/50; A61F; A61F2/00; A61F2/0059; A61F2310/00; A61F2310/00005; A61F2310/00365; A61L2400/00; A61L2400/06

Claims Analysis

Total Claims: 36
Claim 1
Independent Claim 73 words
An injectable implant composition for soft tissue augmentation comprising an aqueous suspension of a particulate biomaterial containing a sufficient amount of a biocompatible fluid lubricant to significantly improve the intrudability of the composition, wherein said particles of biomaterial are fibrils or beads comprising natural or synthetic polymers, and wherein said fluid lubricant comprises a non-fibrillar high molecular weight charged polymer, a high molecular weight neutral polymer, or a low molecular weight neutral molecule.
Claim 2
Dependent Claim 73 words
An injectable implant composition for soft tissue augmentation comprising an aqueous suspension of a particulate biomaterial containing a sufficient amount of a biocompatible fluid lubricant to significantly improve the intrudability of the composition, wherein said particles of biomaterial are fibrils or beads comprising natural or synthetic polymers, and wherein said fluid lubricant comprises a non-fibrillar high molecular weight charged polymer, a high molecular weight neutral polymer, or a low molecular weight neutral molecule.
Claim 3
Dependent Claim 21 words
The composition of claim 1 wherein the particulate biomaterial is fibrillar cross-linked collagen, or beads of a synthetic or natural polymer.
Claim 4
Dependent Claim 42 words
The composition of claim 1 wherein the particles of biomaterial are (a) generally spherical in shape and have diameters in the range of about 1 to 30 microns or (b) are 500-800 microns in length and less than 30 microns in width.
Claim 5
Dependent Claim 23 words
The composition of claim 1 wherein the concentration of particulate biomaterial in the suspension is in the range of 1% to 20% W/V.
Claim 6
Dependent Claim 23 words
The composition of claim 1 wherein the concentration of particulate biomaterial in the suspension is in the range of 3% to 6% W/V.
Claim 7
Dependent Claim 20 words
The composition of claim 1 wherein the concentration of said lubricant in the suspension is about 0.01% to 40% W/V.
Claim 8
Dependent Claim 12 words
The composition of claim 1 wherein the lubricant is a charged polymer.
Claim 9
Dependent Claim 17 words
The composition of claim 7 wherein the charged polymer is methylated collagen, succinylated collagen, or dextran sulfate.
Claim 10
Dependent Claim 35 words
The composition of claim 1 wherein the lubricant is an uncharged polymer selected from the group consisting of dextran, heparin, and glycogen, and the concentration of lubricant in the suspension is 10% to 40% W/V.
Claim 11
Dependent Claim 26 words
The composition of claim 1 wherein the lubricant is neutral, has a low molecular weight, and is present in the suspension at 10% to 40% W/V.
Claim 12
Dependent Claim 22 words
The composition of claim 10 wherein the lubricant is maltose, dextrose, a triglyceride of a fatty acid, egg yold phospholipid, or glycerol.
Claim 13
Dependent Claim 11 words
The composition of claim 1 wherein the lubricant is hyaluronic acid.
Claim 14
Dependent Claim 14 words
The composition of claim 1 wherein the lubricant is soluble in the suspending medium.
Claim 15
Dependent Claim 24 words
The composition of claim 8 wherein the biomaterial is cross-linked collagen and the concentration of biomaterial in the suspension is 3% to 6% W/V.
Claim 16
Dependent Claim 24 words
The composition of claim 9 wherein the biomaterial is cross-linked collagen and the concentration of biomaterial in the suspension is 3% to 6% W/V.
Claim 17
Dependent Claim 24 words
The composition of claim 11 wherein the biomaterial is cross-linked collagen and the concentration of biomaterial in the suspension is 3% to 6% W/V.
Claim 18
Dependent Claim 24 words
The composition of claim 12 wherein the biomaterial is cross-linked collagen and the concentration of biomaterial in the suspension is 3% to 6% W/V.
Claim 19
Independent Claim 76 words
A method of improving the intrudability of a particulate biomaterial into soft tissue comprising incorporating a sufficient amount of a biocompatible fluid lubricant in the suspension to enhance the intrudability of the suspension into the tissue, wherein said particles of biomaterial are fibrils or beads comprising natural or synthetic polymers, and wherein said fluid lubricant comprises a non-fibrillar high molecular weight charged polymer, a high molecular weight neutral polymer, or a low molecular weight neutral molecule.
Claim 20
Independent Claim 76 words
A method of improving the intrudability of a particulate biomaterial into soft tissue comprising incorporating a sufficient amount of a biocompatible fluid lubricant in the suspension to enhance the intrudability of the suspension into the tissue, wherein said particles of biomaterial are fibrils or beads comprising natural or synthetic polymers, and wherein said fluid lubricant comprises a non-fibrillar high molecular weight charged polymer, a high molecular weight neutral polymer, or a low molecular weight neutral molecule.
Claim 21
Dependent Claim 20 words
The method of claim 18 wherein the concentration of said lubricant in the suspension is about 0.01% to 40% W/V.
Claim 22
Dependent Claim 12 words
The method of claim 18 wherein the lubricant is a charged polymer.
Claim 23
Dependent Claim 16 words
The method of claim 20 wherein the charged polymeric methylated collagen, succinylated collagen, or dextran sulfate.
Claim 24
Dependent Claim 35 words
The method of claim 18 wherein the lubricant is an uncharged polymer selected from the group consisting of dextran, heparin, and glycogen and the concentration of lubricant in the suspension is 10% to 40% W/V.
Claim 25
Dependent Claim 26 words
The method of claim 18 wherein the lubricant is neutral, has a low molecular weight and is present in the suspension at 10% to 40% W/V.
Claim 26
Dependent Claim 22 words
The method of claim 23 wherein the lubricant is maltose, dextrose, a triglyceride of a fatty acid, egg yolk phospholipid, or glycerol.
Claim 27
Dependent Claim 11 words
The method of claim 18 wherein the lubricant is hyaluronic acid.
Claim 28
Dependent Claim 24 words
A method for augmenting soft tissue in a living mammal comprising injecting the composition of claim 1 into the mammal at the augmentation site.
Claim 29
Dependent Claim 24 words
A method for augmenting soft tissue in a living mammal comprising injecting the composition of claim 8 into the mammal at the augmentation site.
Claim 30
Dependent Claim 24 words
A method for augmenting soft tissue in a living mammal comprising injecting the composition of claim 9 into the mammal at the augmentation site.
Claim 31
Dependent Claim 24 words
A method for augmenting soft tissue in a living mammal comprising injecting the composition of claim 11 into the mammal at the augmentation site.
Claim 32
Dependent Claim 24 words
A method for augmenting soft tissue in a living mammal comprising injecting the composition of claim 12 into the mammal at the augmentation site.
Claim 33
Dependent Claim 29 words
The composition of claim 1 wherein said biomaterial is selected from fibrillar crosslinked collagen, gelatin beads, polytetrafluoroethylene beads, silicone rubber beads, hydrogel beads, silicon carbide beads, and glass beads.
Claim 34
Dependent Claim 36 words
The composition of claim 1 wherein said fluid lubricant is selected from hyaluronic acid, dextran sulfate, dextran, succinylated non-crosslinked collagen, methylated non-cross-linked collagen, glycogen, glycerol, dextrose, maltose, triglycerides of fatty acids, egg yolk phospholipids, and heparin.
Claim 35
Dependent Claim 29 words
The method of claim 18 wherein said biomaterial is selected from fibrillar cross-linked collagen, gelatin beads, polytetrafluoroethylene beads, silicone rubber beads, hydrogel beads, silicon carbide beads, and glass beads.
Claim 36
Dependent Claim 36 words
The method of claim 18 wherein said fluid lubricant is selected from hyaluronic acid, dextran sulfate, dextran, succinylated non-cross-linked collagen, methylated non-cross-linked collagen, glycogen, glycerol, dextrose, maltose, triglycerides of fatty acids, egg yolk phospholipids, and heparin.

References Cited (Backward Citations)

SU264621A1 Cited
US4107288A Cited
US3949073A Cited
US4233360A Cited
US4617293A Cited
US4442655A Cited
US4424208A Cited
US4440750A Cited
US4582640A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-02-07 1992-08-08 1993-02-07 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-02-07 1996-08-08 1997-02-07 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-02-07 2000-08-08 2001-02-07 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag